freyrsolutions

Performance Evaluation Report (PER), EU IVDR, In Vitro Diagnostic Devices

Personal Care Products Safety Act, USA, FDA

Pharmaceutical Advertising Regulations, OPDP submissions, Drug promotion

Pharmaceutical label management system

Post Market Surveillance Requirements, EU MDR Post Market Surveillance, medical devices

Post-Brexit Updates for Pharma and Medical Device Manufacturers

Regulatory Affairs Services, Regulatory affairs consulting

Regulatory Intelligence, Market Intelligence & Trend Analysis, Reports

Regulatory Labeling Compliance in EU – Free Webinar

Regulatory Labeling Management Software - Freyr Label 360

Regulatory Updates in 2019 on Pharma, Medical Devices, Cosmetics and Food Supplements

Regulatory updates in 2020, pharma, medical devices, cosmetics, supplements

Regulatory updates on European Pharmaceutical Industry

Roles and Responsibilities of an EU qualified person

Scientific Assessment Reports, Position Paper, REACH Registration

Scientific assessment reports, REACH Registration

South Korea MFDS reduces some STED file Submissions for Class IV Medical Devices

SPL software, SPM software, USFDA, Health Canada | Freyr SPL

SPL/SPM Query, SPL/SPM Demo, Software Vendor | Freyr SPL

SPL/SPM software demo request, Product Monographs | Freyr SPL

SPL/SPM software quote request, Structured product Labeling/Monograph | Freyr SPL

Structured Product Labeling, SPL Software, SPL Format | Freyr SPL

Structured Product Labeling, Structure Product Monograph Software

Supply-Chain Regulatory Compliance, Formulation review, INCI

Taiwan FDA’s new Regulations on safety of Cosmetic products

TGA Assessed Claim - Usage on Medicine Labels

TGA Establishes AICIS Replacing the NICNAS

This article talks about the impact of Brexit on pharmaceutical law and recommended actions for pharma companies to be prepared for any of the Brexit outcomes.

UK cosmetics regulatory changes in case of no-deal Brexit

UK Responsible Person (UKRP), UK Responsible Person Medical Devices